Tower Research Capital (TRC)’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-27,672
| Closed | -$261K | – | 5614 |
|
|
2020
Q3 | $261K | Buy |
27,672
+18,619
| +206% | +$176K | ﹤0.01% | 2310 |
|
|
2020
Q2 | $69K | Buy |
+9,053
| New | +$69K | ﹤0.01% | 2795 |
|
|
2020
Q1 | – | Sell |
-5,945
| Closed | -$72K | – | 4359 |
|
|
2019
Q4 | $72K | Sell |
5,945
-5,432
| -48% | -$65.8K | 0.01% | 1130 |
|
|
2019
Q3 | $131K | Sell |
11,377
-8,644
| -43% | -$99.5K | 0.01% | 1197 |
|
|
2019
Q2 | $200K | Buy |
+20,021
| New | +$200K | 0.01% | 852 |
|
|
2018
Q4 | – | Sell |
-8,685
| Closed | -$173K | – | 4621 |
|
|
2018
Q3 | $173K | Buy |
+8,685
| New | +$173K | 0.01% | 1051 |
|
|
2017
Q3 | – | Sell |
-106
| Closed | -$2K | – | 4417 |
|
|
2017
Q2 | $2K | Sell |
106
-1,994
| -95% | -$37.6K | ﹤0.01% | 2418 |
|
|
2017
Q1 | $47K | Sell |
2,100
-897
| -30% | -$20.1K | ﹤0.01% | 766 |
|
|
2016
Q4 | $104K | Buy |
2,997
+1,129
| +60% | +$39.2K | 0.01% | 953 |
|
|
2016
Q3 | $46K | Buy |
+1,868
| New | +$46K | ﹤0.01% | 1199 |
|
|
2015
Q4 | – | Sell |
-476
| Closed | -$19K | – | 5338 |
|
|
2015
Q3 | $19K | Sell |
476
-630
| -57% | -$25.1K | ﹤0.01% | 1788 |
|
|
2015
Q2 | $76K | Sell |
1,106
-3,608
| -77% | -$248K | 0.01% | 1058 |
|
|
2015
Q1 | $258K | Sell |
4,714
-526
| -10% | -$28.8K | 0.03% | 309 |
|
|
2014
Q4 | $223K | Buy |
5,240
+2,129
| +68% | +$90.6K | 0.02% | 277 |
|
|
2014
Q3 | $99K | Buy |
+3,111
| New | +$99K | 0.01% | 968 |
|
|
2014
Q2 | – | Sell |
-670
| Closed | -$13K | – | 4913 |
|
|
2014
Q1 | $13K | Sell |
670
-1,244
| -65% | -$24.1K | ﹤0.01% | 2375 |
|
|
2013
Q4 | $46K | Buy |
1,914
+1,469
| +330% | +$35.3K | 0.01% | 1468 |
|
|
2013
Q3 | $10K | Buy |
445
+23
| +5% | +$517 | ﹤0.01% | 3225 |
|
|
2013
Q2 | $9K | Buy |
+422
| New | +$9K | ﹤0.01% | 2489 |
|